Research Center
Stay current with the latest prostate health research, clinical trials, and emerging technologies.
The Evolving Role of Active Surveillance in Low-Risk Prostate Cancer
Dr. Priyadarshi Ranjan discusses how active surveillance protocols have matured, with 15-year outcome data showing comparable survival rates to immediate treatment for carefully selected low-risk patients.
Source: Prostate Care Global
AI-Powered Pathology Improves Gleason Grading Accuracy
Artificial intelligence algorithms trained on millions of prostate biopsy images have demonstrated 95% accuracy in Gleason grading, matching or exceeding expert pathologists.
Source: Nature Medicine
Phase III Trial of Novel PSMA-Targeted Therapy for Metastatic Prostate Cancer
A Phase III clinical trial evaluating a new PSMA-targeted radioligand therapy has shown a 40% improvement in progression-free survival for men with metastatic castration-resistant prostate cancer.
Source: Journal of Clinical Oncology
MRI-Guided Biopsy Shows Superior Detection of Clinically Significant Prostate Cancer
A large multicenter trial comparing MRI-guided biopsy with standard systematic biopsy found that MRI-guided approaches detected 30% more clinically significant cancers while reducing overdiagnosis of low-grade disease.
Source: The New England Journal of Medicine